COVID-19 primary infection, reinfection, and its associated clinical presentations
Frontiers in Public Health · 14.04.2026 · 14
DOI: 10.3389/fpubh.2026.1695310 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Public Health, online erschienen am 14.04.2026. Verfasst von Varuni Makam und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, JSS Medical College and Hospital, JSS Academy of Higher Education and Research (JSS AHER), Mysuru, India. Hauptthemen laut MEDLINE: Reinfection, COVID-19. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Indian Council of Medical Research.
Abstract (Originalsprache)
Introduction
SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus-2), which caused primary COVID-19 infection in millions worldwide, raised significant concerns as viral mutations emerged, leading to reinfections among previously infected and vaccinated individuals. This phenomenon became particularly evident during the second and third waves of the COVID-19 pandemic in India.
Methods
The current study observed the rates of reinfections due to SARS-CoV-2 and their relation to vaccination details by retrospectively analyzing the data of patients who had reinfections during the second and third waves of COVID-19.
Results
Among the 458 study participants, 62/458 (13.54%) with primary infection had confirmed re-infection. Of the 458 people infected with COVID-19 for the first time, 60 (13%) were asymptomatic and 398 (87%) were symptomatic. The most frequently observed symptoms were fever during primary (70.3%) and re-infection (72.58%). A statistically significant association was observed between vomiting symptoms and infection status ( p < 0.01).
Conclusions
SARS-CoV-2 is re-emerging with new variants and varied presentations, posing a challenge to clinicians regarding specific diagnoses. The symptoms of COVID-19 during primary and re-infection did not differ greatly. Although vaccination protects individuals against reinfections, the exact duration of protection remains unknown and may necessitate booster doses at frequent intervals.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology, JSS Medical College and Hospital, JSS Academy of Higher Education and Research (JSS AHER), Mysuru, India.
- Department of Community Medicine, JSS Medical College and Hospital, JSS Academy of Higher Education and Research (JSS AHER), Mysuru, India.
Förderung
- Indian Council of Medical Research
Zitieren
APA
Makam, V., Chitharagi, V. B., A, T., Rao, M. R., Chandrashekarappa, S., & Maheshwarappa, Y. D. (2026). COVID-19 primary infection, reinfection, and its associated clinical presentations. Frontiers in Public Health, 14. https://doi.org/10.3389/fpubh.2026.1695310
Vancouver
Makam V, Chitharagi VB, A T, Rao MR, Chandrashekarappa S, Maheshwarappa YD. COVID-19 primary infection, reinfection, and its associated clinical presentations. Frontiers in Public Health. 2026;14. doi:10.3389/fpubh.2026.1695310
BibTeX
@article{Makam2026,
author = {Makam, Varuni and Chitharagi, Vidyavathi B and A, Tejashree and Rao, Morubagal Raghavendra and Chandrashekarappa, Smitha and Maheshwarappa, Yogeesh D},
title = {COVID-19 primary infection, reinfection, and its associated clinical presentations},
journal = {Frontiers in Public Health},
year = {2026},
volume = {14},
doi = {10.3389/fpubh.2026.1695310}
}
EUVIMED